Editor's Note
The Food and Drug Administration (FDA) on April 23 issued a new draft guidance to help manufacturers avoid delays in preparing, planning, and executing voluntary recalls.
The guidance includes recommendations in three areas:
The guidance is the latest step in the agency’s commitment to working with companies to quickly act to protect consumers from potentially dangerous products, the FDA says.
Read More >>Takeaways • Determining the return on investment (ROI) for a…
The centralization of medical device processing to one facility is…
Takeaways • Robot-assisted surgery (RAS) is now an option in…
Free Daily News